Overview
DERM market data
Price History
DERM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.47 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.06 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -14.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.31 – $9.56 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $183.1M · P/B 6.57 · P/S 2.83.
Company News
B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15Benzinga · Aug 13, 2026, 1:15 PM
Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M EstimateBenzinga · Aug 12, 2026, 8:02 PM
Journey Medical shares are trading higher after the company reported better-than-expected Q1 sales results.Benzinga · May 14, 2026, 4:02 PM